- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avicanna Inc (AVCN)
Avicanna Inc stock price live, this page displays TSX AVCN stock exchange data. View the AVCN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Avicanna Inc real time stock price chart below.
What Is the Avicanna Inc Stock Price Today?
The Avicanna Inc stock price today is 0.135.
What Is the Stock Symbol for Avicanna Inc?
The stock symbol for Avicanna Inc is "AVCN."
What Stock Exchange Does Avicanna Inc Trade On?
Avicanna Inc is listed and trades on the Toronto stock exchange.
Is Avicanna Inc a Good Stock to Buy?
Determining whether Avicanna Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVCN quote. (ISIN: CA05368K1003)
What Is the Avicanna Inc Stock Price Today?
The Avicanna Inc stock price today is 0.135.
What Is the Stock Symbol for Avicanna Inc?
The stock symbol for Avicanna Inc is "AVCN."
What Stock Exchange Does Avicanna Inc Trade On?
Avicanna Inc is listed and trades on the Toronto stock exchange.
Is Avicanna Inc a Good Stock to Buy?
Determining whether Avicanna Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVCN quote. (ISIN: CA05368K1003)
Toronto
Currency in CAD
0.135
+0.005(+3.85%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.135
0.135
52 wk Range
0.095
0.298
Earnings results expected in 4 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1350.135
52 wk Range
0.0950.298
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AVCN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Not profitable over the last twelve months
Avicanna names Nick Hilborn as permanent CFO- Investing.com
- Avicanna names Nick Hilborn as permanent CFO
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Avicanna Inc Earnings Call Summary for Q4/2025
- Avicanna achieved quarterly profitability with Q4 adjusted EBITDA of CAD 310,000; gross margin expanded 10 points to 53%
- Annual revenue flat at CAD 25.5M; MyMedi.ca platform contributed 80% of total revenue in strategic shift to profitability
- Net loss improved 41% to CAD 2.7M from CAD 4.6M in 2024; full-year adjusted EBITDA loss of CAD 300,000
- Company projects FY2026-27 revenue at USD 18.3M; plans next-gen 3.0 product line launch by end of 2026
- Stock unchanged at $0.15; faces challenges from Canadian market saturation and international regulatory complexity
Last Updated: 2026-04-07, 08:50 a/m
Read Full TranscriptEarnings
Latest Release
May 13, 2026
EPS / Forecast
-- / --
Revenue / Forecast
6.68M / --
Compare AVCN to Peers and Sector
Metrics to compare | AVCN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVCNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.6x | −2.6x | −0.3x | |
PEG Ratio | −0.28 | 0.00 | 0.00 | |
Price/Book | 4.5x | 0.7x | 2.6x | |
Price / LTM Sales | 0.7x | 0.8x | 3.1x | |
Upside (Analyst Target) | - | 58.8% | 48.3% | |
Fair Value Upside | Unlock | 4.8% | 6.7% | Unlock |
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific cannabinoid-based candidates to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, as well as Trunerox, an indication-specific drug treatment for seizure associated with Lennox-Gastaut Syndrome and Dravet Syndrome. The company also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, it operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, as well as provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens; and collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator’s various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Avicanna (AVCN) Stock Price Today?
The Avicanna stock price today is 0.135 CAD.
What Stock Exchange Does Avicanna Trade On?
Avicanna is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Avicanna?
The stock symbol for Avicanna is "AVCN."
What Is the Avicanna Market Cap?
As of today, Avicanna market cap is 17.470M CAD.
What Is Avicanna's Earnings Per Share (TTM)?
The Avicanna EPS (TTM) is -0.027.
When Is the Next Avicanna Earnings Date?
Avicanna will release its next earnings report on Aug 17, 2026.
From a Technical Analysis Perspective, Is AVCN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Avicanna Stock Split?
Avicanna has split 0 times.
How Many Employees Does Avicanna Have?
Avicanna has 112 employees.
What is the current trading status of Avicanna (AVCN)?
As of Aug 13, 2026, Avicanna (AVCN) is trading at a price of 0.135 CAD, with a previous close of 0.130 CAD. The stock has fluctuated within a day range of 0.135 CAD to 0.135 CAD, while its 52-week range spans from 0.095 CAD to 0.298 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.